During the past decade, Dallas Heart Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dallas Heart Group" are "Bradycardia" (1 trials), "Heart Disease" (1 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Tachycardia" (1 trials). Many other conditions were trialed in "Dallas Heart Group" in a lesser frequency.

Most popular intervention types in "Dallas Heart Group" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cardiac Rhythm Management device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Heart Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Heart Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dallas Heart Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Heart Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".